Doxorubicin (SIOGEN Biotech)

N/A

Report date: 2026/01/26 13:50:15

Base Information

Drug NameDoxorubicin (SIOGEN Biotech)

Drug Alias Namedoxorubicin

ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Anthracycline antibiotics

Mechanisms of ActionTopoisomerase II inhibitorsVirus DNA polymerase inhibitors

TargetsTopoisomerase IIVirus DNA polymerase

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMalaysia

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesSIOGEN Biotech

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesSIOGEN Biotech

Active IndicationsN/A

Inactive IndicationsNeoplasms

ATC CodeN/A